Peptide Lab Verification — Purity and Identity

What "lab verified" actually means

"Lab verified" is a phrase that appears on a great many research-peptide listings and means nothing on its own. Behind it there should be two complementary analytical techniques answering two different questions: high-performance liquid chromatography, which asks how much of this sample is one thing, and mass spectrometry, which asks whether that thing is the compound named on the label. Neither answers the other's question, and a claim that rests on only one of them is incomplete.

The document that ties both results to a specific production batch is the Certificate of Analysis. A supplier that publishes a per-lot COA from an independent laboratory is making a checkable claim. A supplier that publishes a purity percentage in body copy, with no chromatogram, no lot number and no issuing laboratory, is making an unverifiable one — and the two are easy to mistake for each other at a glance.

Purity and identity are separate questions

A chromatogram can show a single sharp peak — the signature of a very pure sample — while the molecule producing that peak is not the peptide on the label. Purity describes homogeneity; identity describes what the homogeneous material actually is. This is why the two methods are always cited together in a credible verification package.

HPLC purity is conventionally expected at 99% or above for research-grade peptides, reported as a percentage of total peak area. Mass spectrometry confirms that the measured molecular mass matches the mass predicted from the stated amino-acid sequence, within a declared tolerance. Together they establish that the vial contains mostly one compound and that the compound is the intended one.

The verification stack

• HPLC purity — separation by chromatography, with the result expressed as the area of the main peak relative to total peak area. The chromatogram itself is the evidence; the number is a summary of it.
• Mass spectrometry — measurement of mass-to-charge ratio, from which the neutral molecular mass is derived and compared against the theoretical mass of the stated sequence.
• Certificate of Analysis — the document that binds those results to one lot, one test date and one issuing laboratory.
• Lot traceability — the lot number on the COA has to match the lot number printed on the vial in hand. A COA that cannot be matched to a specific vial documents some other batch.
• Third-party issuance — analysis performed by a laboratory independent of the seller. A COA produced by the supplier's own laboratory is not equivalent evidence, whatever the numbers on it say.

What a Certificate of Analysis does not establish

Reading a COA well means knowing its limits as precisely as its contents.

Purity is not potency. Purity is the proportion of the sample that is the target compound. Potency is the amount required to produce a given effect. Highly pure material that has partially degraded or misfolded can be correspondingly less active, and a purity figure will not reveal that.

Purity is not net peptide content. A lyophilised vial contains counterions, residual water and often an excipient added to protect the peptide during freeze-drying. Peptide content — the proportion of the vial's mass that is actually peptide — is a separate measurement, and a thorough COA reports it separately.

A COA describes a lot at a moment. It documents the material as tested, on the test date. It says nothing about what shipping temperature, elapsed time, or a freeze-thaw cycle may have done to the vial that arrived. Stability is a property of handling, not of the certificate.

A COA is not a regulatory approval. Analytical documentation and regulatory status are unrelated. A research-grade compound with an immaculate COA remains a research-grade compound — see research grade versus pharmaceutical grade for the distinction.

What careful researchers check beyond the numbers

• The issuing laboratory is named, with contact details or an accreditation reference — not simply "third-party tested".
• The test date is reasonably close to the lot date, so the document describes recently characterised material.
• The compound name and lot number on the COA match the listing and the vial label exactly.
• The chromatogram is legible and unclipped, with its axes visible, rather than a cropped image of a peak.
• The analytical methods listed are appropriate to the compound class — a protein-scale entry and a tripeptide are not characterised identically.
• Where a supplier publishes COAs across multiple lots, the results are consistent rather than uniformly and implausibly identical.

Where verification stops

Analytical verification establishes chemistry, and nothing else. It does not establish that a compound is safe, effective, or appropriate for any use, and no COA should be read as implying any of those things. PeptiDex documents these methods so that researchers can assess the material they are working with; every entry in the library remains a research compound, documented for research and educational purposes only.